Clinical Trials in Chicago

Showing 3121-3140 of 20,493 trials

Randomized Withdrawal Study in Patients With Schizophrenia

NCT06961968

The purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in patients with schizophrenia.

Schizophrenia

Vanda Pharmaceuticals400 participantsStarted May 2025

Rogers, Arkansas, United States • Costa Mesa, California, United States • Lemon Grove, California, United States +19 more locations

Not Yet RecruitingPhase 22.2 miles

FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

NCT07332741

The goal of this clinical trial is to treat both hypertension and obesity in adults using a food is medicine framework. Participants will be randomized 1:1 to FIM+DASH or usual-care control. The 24-week trial includes a 12-week FIM+DASH intervention followed by a 12-week maintenance period and leverages existing partnerships with community-based organizations for home food delivery and culinary skill-skill building. The main questions it aims to answer are: (1) What is the effect of FIM+DASH vs. usual care control on blood pressure? (2) What is the effect of FIM+DASH vs. usual care control on DASH diet adherence (diet quality), body weight, and waist circumference? (3) How to identify factors associated with the sustainability and scalability of FIM+DASH in real-world settings?

HypertensionHypertension (HTN)Obesity & Overweight

University of Illinois at Chicago150 participantsStarted Mar 2026

Chicago, Illinois, United States • Chicago, Illinois, United States • Chicago, Illinois, United States +1 more locations

Randomized Withdrawal Study in Patients With Schizophrenia

FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

Find Trials by Condition in Chicago

SGLT2i in Kidney Stones

A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome

Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma

Pragmatic Use of PAIN-Advanced Dementia Scale in Emergency Departments

IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies

A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.

The PROTEMBO Trial

IC-8 Apthera IOL New Enrollment Post Approval Study

Evaluating Therapeutic Electrical Stimulation to Improve Nerve Healing After Surgical Repair of Digital Nerve Injuries

CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation

Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study

CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)

Discharge Stewardship in Children's Hospitals

STimulation to Activate RespIration

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress